About Filisia
Filisia is a company based in London (United Kingdom) founded in 2014 by Georgios Papadakis. It operates as a SaaS and D2C. Filisia has raised $258.19 thousand across 2 funding rounds from investors including European Union and Deepbridge Capital. Filisia offers products and services including Cosmo, Cosmo Explore, Cosmo Excel, Cosmo Home, and Cosmo Pro. Filisia operates in a competitive market with competitors including MicroHealth, Twill, BioSymetrics, Cardio Renal and Theratrak, among others.
- Headquarter London, United Kingdom
- Founders Georgios Papadakis
-
Sectors
TechnologyEducation
-
Phone
*********
-
Website
*********
-
Social
*********
- Legal Name Filisia Interfaces Ltd
- Date of Incorporation 02 Jun, 2014
- Jurisdiction LONDON
-
Annual Revenue
-
Net Profit
-
EBITDA
-
Total Equity Funding
$258.19 K (USD)
in 2 rounds
-
Latest Funding Round
$258.19 K (USD), Seed
Apr 29, 2019
-
Investors
European Union
& 1 more
-
Employee Count
Employee Count
Unlock complete access to The Company Check
Get unrestricted viewing across everything we track — from companies and brands to investors, funding rounds, acquisitions, financials, and more.
- Unlimited viewing on all profiles Companies, investors, financials, funding, acquisitions & directors
- Full access to every database India & global coverage, advanced filters and rich profile details
- Always-on access from your team account Single premium plan for everything you see on the portal
Products & Services of Filisia
Filisia offers a comprehensive portfolio of products and services, including Cosmo, Cosmo Explore, Cosmo Excel, Cosmo Home, and Cosmo Pro.
Interactive tool for inclusive learning and therapy for people with disabilities
Exploratory application for learning needs and play activities
Advanced therapy-focused platform for cognitive development
Home-based inclusive tools for daily learning and therapy
Subscription for advanced therapy and educational features
People of Filisia
Unlock access to complete
Funding Insights of Filisia
Filisia has successfully raised a total of $258.19K across 2 strategic funding rounds. The most recent funding activity was a Seed round of $258.19 thousand completed in April 2019. This substantial capital infusion reflects strong investor confidence in the company's business model, growth potential, and market opportunities. The funding enables strategic expansion, product development, market penetration, and operational scaling to drive long-term value creation and competitive advantage.
- Total Funding Total Funding
- Total Rounds 2
- Last Round Seed — $258,185
-
First Round
First Round
(01 Aug 2016)
- Investors Count 2
| Date | Amount | Transaction Name | Valuation | Lead Investors | Investors |
|---|---|---|---|---|---|
| Apr, 2019 | Amount | Seed - Filisia | Valuation | Deepbridge Capital |
|
| Aug, 2016 | Amount | Grant - Filisia | Valuation |
investors |
Investors in Filisia
Filisia has secured backing from 2 investors, including venture fund and institutional investors. Prominent investors backing the company include European Union and Deepbridge Capital.
| Investor | Description | Founded Year | Domain | Location |
|---|---|---|---|---|
|
Deepbridge Capital is focused on tax-efficient investment opportunities.
|
Founded Year | Domain | Location | |
|
Government entites focused on freedom, democracy, equality and the rule of law, promoting peace and stability
|
Founded Year | Domain | Location |
Investments & Acquisitions by Filisia
Financial Statements - Filisia
Filisia Comparisons
Competitors of Filisia
Filisia operates in a dynamic and competitive business environment, facing competition from various established players and emerging companies in the market. The competitive landscape includes prominent companies such as MicroHealth, Twill, BioSymetrics, Cardio Renal and Theratrak, among others.
| Company Name | Domain | Founded year | HQ Location | Description |
|---|---|---|---|---|
| domain | founded_year | HQ Location |
Population health management and care coordination solutions are provided.
|
|
| domain | founded_year | HQ Location |
Evidence-based digital therapeutics and wellness apps for healthcare are provided.
|
|
| domain | founded_year | HQ Location |
Provider of a cognitive computing-based biomedical intelligence platform
|
|
| domain | founded_year | HQ Location |
Digital therapeutics for chronic kidney disease management are provided.
|
|
| domain | founded_year | HQ Location |
Provider of the app for physical therapists
|
Latest news on Filisia
Frequently Asked Questions about Filisia
Filisia was founded in 2014 and raised its 1st funding round 2 years after it was founded.
Filisia is headquartered in London, United Kingdom. It is registered at London, England, United Kingdom.
Georgios Papadakis is the current CEO of Filisia. They have also founded this company.
Filisia is a funded company, having raised a total of $258.19K across 2 funding rounds to date. The company's 1st funding round was a Grant of $55.83K, raised on Aug 01, 2016.
Cosmo, developed by Filisia, focuses on re-imagining inclusive education and therapy through interactive tools for people with learning disabilities, autism, and other conditions. It combines evidence-based approaches for learning, play, and rehabilitation, accessible via subscriptions or purchases. Based in London, United Kingdom, it serves users with special needs, including those with cerebral palsy or Down syndrome, emphasizing accessibility and impact through digital platforms.
Filisia's top competitors include BioSymetrics, Twill and MicroHealth.
Filisia offers Cosmo, Cosmo Explore, Cosmo Excel, Cosmo Home, and Cosmo Pro.
Filisia has 2 investors. Key investors include European Union, and Deepbridge Capital.